Chase AIPricingFAQs
Display currency
Loading news…

AnGes

Tokyo, Japan

AnGes is a biopharmaceutical company specialized in HGF plasmid, NFkB decoy oligonucleotide, and therapeutic vaccines.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
1
Investments
5
1 exits
Monthly Visits
Available in Pro
Contacts
5
Patents
0
6 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
1
Patents granted
0
Trademarks
6
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$9M

Investor Activity

Investments
5
Lead investments
4
Portfolio orgs
4
Exits
1

Company Info

Org types
company, investor
HQ
Tokyo, Japan

Signals & Scores

Trend (7d)
2.4
Trend (30d)
3.7
Trend (90d)
0

Investments by AnGes

Loading columns…
0 of 0Show
Page 1 / 1

Acquisitions by AnGes

Loading columns…
0 of 0Show
Page 1 / 1

Key People at AnGes

Founder, President and CEO
5
professional contacts at AnGes
Contact execs at AnGes

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to AnGes

Loading news…

FAQs about AnGes

People who checked this page also checked these

Browse the full Acquirezy directory.
AnGes - Company Profile, Full Acquisitions List, Funding and Investments